
Sign up to save your podcasts
Or


Today’s No-BS AI Briefing unpacks a pivotal moment in AI: the sudden wave of agentic AI product launches from Rescale, ZeroPath, Shoplazza, Nokia, and Group-IB. Host Vikash Sharma explains why this marks a shift from hype to production for builders. We also cover Isomorphic Labs' massive $2.1 billion funding round for AI drug discovery, the CME Group's plans for an AI compute futures market, and geopolitical tensions impacting model access like China's denial for Anthropic's "Mythos" model. Plus, a huge AI funding surge for CYBERCOM. Vikash offers a practical takeaway: audit your own workflows for agentic opportunities to stay ahead. Hit follow to catch the next episode and keep building without the noise.
Send us Fan Mail
Support the show
By VikashToday’s No-BS AI Briefing unpacks a pivotal moment in AI: the sudden wave of agentic AI product launches from Rescale, ZeroPath, Shoplazza, Nokia, and Group-IB. Host Vikash Sharma explains why this marks a shift from hype to production for builders. We also cover Isomorphic Labs' massive $2.1 billion funding round for AI drug discovery, the CME Group's plans for an AI compute futures market, and geopolitical tensions impacting model access like China's denial for Anthropic's "Mythos" model. Plus, a huge AI funding surge for CYBERCOM. Vikash offers a practical takeaway: audit your own workflows for agentic opportunities to stay ahead. Hit follow to catch the next episode and keep building without the noise.
Send us Fan Mail
Support the show